Although a substantial amount of studies suggests that Aβ pathology drives neurofibrillary tangles in Alzheimer’s disease, emerging preclinical evidence indicates that tau pathology can progress independently of Aβ accumulation, and arises downstream of genetic risk factors for Alzheimer’s disease.48 The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.